){kind=logo}
Represented Maxim Group LLC as sole placement agent in connection with the $4.5 million public offering of INVO Bioscience, Inc. a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell medical device and the intravaginal culture (“IVC”) procedure.
Loeb’s IP/patent team conducted patent and IP diligence and drafted and negotiated IP provisions of the Registration Statement, opinions of IP counsel, investor presentation and transaction documents.
-
Partner -
-
Partner